secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0001562762-22-000036
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical Q4 sales $250M (+7.1% YoY); FY21 sales $958.1M (+21.4%); guides FY22 sales $1.025B
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS $0.14, non-GAAP $0.49; GAAP net income $15.1M down 71.5% due to IPR&D acquisition
- Full-year GAAP EPS $1.44, non-GAAP EPS $2.04; adjusted EBITDA $331.4M (34.6% of sales)
- Enabling Technology revenue Q4 $25M, FY $81M (+100% YoY); US Spine +18%, International +12%
- FY 2022 guidance: net sales $1.025B, non-GAAP diluted EPS $2.10; company remains debt-free
- Free cash flow for FY 2021 was $219.4M

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000036/0001562762-22-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000036/gmed-20220217x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer